Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Advancing therapy for neuroblastoma
Bo Qiu, Katherine K. Matthay
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 8, pp. 515-533
Closed Access | Times Cited: 228
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma
Konstantin Helmsauer, Maria E. Valieva, Salaheddine Ali, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 160
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
Cécile Thirant, Agathe Peltier, Simon Durand, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression
Hui Shi, Ting Tao, Brian J. Abraham, et al.
Science Advances (2020) Vol. 6, Iss. 29
Open Access | Times Cited: 77
Neuroblastoma and the epigenome
Irfete S. Fetahu, Sabine Taschner‐Mandl
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 1, pp. 173-189
Open Access | Times Cited: 71
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Zsuzsanna Nagy, Janith A. Seneviratne, Maxwell Kanikevich, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
Kristina Lundberg, Diana Treis, John Inge Johnsen
Current Oncology Reports (2022) Vol. 24, Iss. 8, pp. 1053-1062
Open Access | Times Cited: 53
TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation
Martin Fischer, Robert Schwarz, Konstantin Riege, et al.
NAR Cancer (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 43
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
Sven Hagemann, Danny Misiak, Jessica L. Bell, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets
Nathan M. Kendsersky, Michal Odrobina, Nathaniel W. Mabe, et al.
Neuro-Oncology (2025)
Open Access | Times Cited: 1
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
Lu Wang, Tze King Tan, Adam D. Durbin, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 76
Innovations in 3D Tissue Models of Human Brain Physiology and Diseases
Michael L. Lovett, Thomas J.F. Nieland, Yu‐Ting L. Dingle, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 44
Open Access | Times Cited: 69
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G. DuBois, et al.
European Journal of Cancer (2020) Vol. 136, pp. 52-68
Open Access | Times Cited: 67
Core transcriptional regulatory circuitries in cancer
Ye Chen, Liang Xu, Ruby Yu‐Tong Lin, et al.
Oncogene (2020) Vol. 39, Iss. 43, pp. 6633-6646
Open Access | Times Cited: 59
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
Margot Gautier, Cécile Thirant, Olivier Delattre, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2904-2904
Open Access | Times Cited: 48
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis
Xiaowei Liu, Yuanxia Cai, Cheng Cheng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 34
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Super enhancer-associated circRNA-circLrch3 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis by formation of R-loop with host gene
Huiyu Liu, Yuan Jiang, R. Shi, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 130853-130853
Closed Access | Times Cited: 8
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
Deblina Banerjee, Sukriti Bagchi, Zhihui Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Yi He, Wenyong Long, Qing Liu
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 53
Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers
Natalie Andersson, Björn Bakker, Jenny Karlsson, et al.
Cancer Research (2020) Vol. 80, Iss. 7, pp. 1512-1523
Open Access | Times Cited: 47
Combinational therapeutic targeting of BRD4 and CDK7 synergistically induces anticancer effects in head and neck squamous cell carcinoma
Wei Zhang, Han Ge, Yue Jiang, et al.
Cancer Letters (2019) Vol. 469, pp. 510-523
Closed Access | Times Cited: 46
A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells
Lei Guo, Jia Li, Hongxiang Zeng, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma
Emel Rothzerg, Xuan Dung Ho, Jiake Xu, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1132-1132
Open Access | Times Cited: 37
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes, Lisa Depestel, Liselot Mus, et al.
Science Advances (2022) Vol. 8, Iss. 28
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top